. . . . . . . . . . . . . . . . . . . . . "kin(p(MGI:Insr)) -> p(MGI:Irs1)" . "p(MGI:Rbp4) -| (kin(p(MGI:Insr)) -> p(MGI:Irs1))" . "Approximately 61,000 statements." . "Copyright (c) 2011-2012, Selventa. All rights reserved." . "BEL Framework Large Corpus Document" . . "1.4" . "Conversely, insulin-stimulated PI(3)K activity was increased by 80% in muscle of both Rbp+/- and Rbp4-/- mice compared with control mice (Fig. 5b). However, PI(3)K activity was not altered in the liver of RBP4-Tg (Fig. 5c) or Rbp4-/- mice (Fig. 5d). Consistent with these observations, RBP4 injection for 21 days in wild-type mice caused a 34% reduction in insulin-stimulated PI(3)K activity in muscle, but no alteration in liver (Fig. 5e). Furthermore, RBP4 treatment resulted in a 24% reduction in insulin-stimulated tyrosine phosphorylation of insulin receptor substrate-1 (IRS1) at tyrosine residue 612 (Fig. 5f), an important docking site for the p85 subunit of PI(3)K23." . . "Selventa" . . . . "2014-07-03T14:30:36.954+02:00"^^ . . .